From the publishers of JADPRO

MPN Resource Center

Advertisement

A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasms

Last Updated: Thursday, April 15, 2021

A systematic review and meta-analysis of 10 nonrandomized trials involving 1,295 patients with MPNs with a history of venous thromboembolism found that recurrence risk may be lowest among those patients who received anticoagulation combined with cytoreduction therapy. The authors noted, however, that the trials studied had a high risk of bias, which may have led to inconsistent or imprecise findings.

Blood Advances
Advertisement
News & Literature Highlights
Advertisement
Advertisement